Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.24 SEK | +6.23% | +21.35% | +13.68% |
Apr. 25 | Medivir Gets Two US FDA Designations for MIV-711 | MT |
Mar. 21 | Certain Shares of Medivir AB are subject to a Lock-Up Agreement Ending on 21-MAR-2024. | CI |
Sales 2024 * | 26.75M 2.45M | Sales 2025 * | 52.18M 4.77M | Capitalization | 363M 33.18M |
---|---|---|---|---|---|
Net income 2024 * | -96M -8.78M | Net income 2025 * | -93M -8.5M | EV / Sales 2024 * | 10 x |
Net cash position 2024 * | 94.7M 8.66M | Net cash position 2025 * | 58M 5.3M | EV / Sales 2025 * | 5.85 x |
P/E ratio 2024 * |
-3.58
x | P/E ratio 2025 * |
-2.56
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.69% |
Latest transcript on Medivir AB
1 day | +6.23% | ||
1 week | +21.35% | ||
Current month | +17.93% | ||
1 month | +14.14% | ||
3 months | -10.74% | ||
6 months | -58.40% | ||
Current year | +13.68% |
Managers | Title | Age | Since |
---|---|---|---|
Jens Lindberg
CEO | Chief Executive Officer | 53 | 22-01-23 |
Director of Finance/CFO | 50 | 19-08-11 | |
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Uli Alf Hacksell
CHM | Chairman | 74 | 18-05-02 |
Director/Board Member | 68 | 18-05-02 | |
Yilmaz Mahshid
BRD | Director/Board Member | 45 | 20-05-25 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 3.24 | +6.23% | 440,998 |
24-04-25 | 3.05 | +10.51% | 355,255 |
24-04-24 | 2.76 | 0.00% | 126,115 |
24-04-23 | 2.76 | -3.16% | 431,759 |
24-04-22 | 2.85 | +6.74% | 243,245 |
Delayed Quote Nasdaq Stockholm, April 26, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.68% | 33.11M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- MVIR B Stock